The centrifuge brake impacts neither routine coagulation assays nor platelet count in platelet-poor plasma

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Measurement uncertainty: light in the shadows
4. Review
5. Childhood obesity: an overview of laboratory medicine, exercise and microbiome
6. Mini review
7. The utility of measurement uncertainty in medical laboratories
8. Opinion Paper
9. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
10. Opinion Papers
11. The current status and future prospects of precision medicine
12. Precision medicine in medical oncology: hope, disappointment and reality
13. IFCC Papers
14. Laboratory practices to mitigate biohazard risks during the COVID-19 outbreak: an IFCC global survey
15. Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey
16. Genetics and Molecular Diagnostics
17. Diverse fragment lengths dismiss size selection for serum cell-free DNA: a comparative study of serum and plasma samples
18. General Clinical Chemistry and Laboratory Medicine
19. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient
20. Isotope dilution-LC-MS/MS method for quantification of the urinary cotinine-to-creatinine ratio
21. A liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay to profile 20 plasma steroids in endocrine disorders
22. Assessment of antinuclear antibodies by indirect immunofluorescence assay: report from a survey by the American Association of Medical Laboratory Immunologists
23. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis
24. Reference Values and Biological Variations
25. Continuous, complete and comparable NT-proBNP reference ranges in healthy children
26. Reference-mean-centered statistical quality control
27. Hematology and Coagulation
28. Top-down and bottom-up approaches for the estimation of measurement uncertainty in coagulation assays
29. Cancer Diagnostics
30. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer
31. Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma
32. Cardiovascular Diseases
33. Establishing the 99th percentile of a novel assay for high-sensitivity troponin I in a healthy blood donor population
34. The clinically effective use of cardiac markers by restructuring laboratory profiles at Cardiology wards
35. Infectious Diseases
36. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital
37. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics
38. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing
39. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
40. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays
41. Letters to the Editor
42. Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China
43. Blood sampling after COVID-19 − How to organize large scale phlebotomy services in the post SARS CoV-2 era
44. Diagnostic performance of a SARS-CoV-2 IgG/IgM lateral flow immunochromatography assay in symptomatic patients presenting to the emergency department
45. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19)
46. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients – a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China
47. Low levels of total and ionized calcium in blood of COVID-19 patients
48. Is “light cannabis” really light? Determination of cannabinoids content in commercial products
49. Amino-terminal proB-type natriuretic peptide reference values in umbilical cord blood
50. The new era of LED microscopes in immunofluorescence anti-nuclear antibody (ANA) testing
51. The centrifuge brake impacts neither routine coagulation assays nor platelet count in platelet-poor plasma